Specifically, laboratory tests that should be prioritized to determine patient risk of developing severe COVID-19 pneumonia, include lymphopenia, NLR, thrombocytopenia, CRP, D-Dimer, creatinine, LDH, CK, troponin and NT-Pro-BNP. This evidence concerns the gene CRP and lymphopenia.